Crinetics Pharmaceuticals, Inc.
Symbol: CRNX (NASDAQ)
40.53
▼ (-2.37%) -0.985
Company Description:
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
Key Stats
- Today's Open: $41.72
- Today's High: $42.051
- Today's Low: $40.336
- Today's Volume: 1.39M
- Yesterday Close: $41.51
- Yesterday High: $42.177
- Yesterday Low: $40.9851
- Yesterday Volume: 1.37M
- Last Min Volume: 16
- Last Min High: $40.525
- Last Min Low: $40.525
- Last Min VWAP: $40.525
Company Profile
- Name: Crinetics Pharmaceuticals, Inc.
- Website: https://www.crinetics.com
- Listed Date: 2018-07-18
- Location: SAN DIEGO, CA
- Market Status: Active
- CIK Number: 0001658247
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $3.91B
- Round Lot: 100
- Outstanding Shares: 94.18M
- Asset Type: CS
RECENT FILINGS FOR CRNX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-03 | 4 | View |
| 2025-10-01 | 144 | View |
| 2025-09-30 | 4 | View |
| 2025-09-30 | 4 | View |
| 2025-09-26 | 144 | View |
| 2025-09-26 | 144 | View |
| 2025-09-26 | 8-K | View |
| 2025-09-08 | SCHEDULE 13G | View |
| 2025-09-04 | 4 | View |
| 2025-09-02 | 144 | View |
| 2025-08-26 | 4 | View |
| 2025-08-22 | 144 | View |
| 2025-08-21 | 4 | View |
| 2025-08-20 | 144 | View |
| 2025-08-12 | SCHEDULE 13G/A | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-06-30 | 8-K | View |
| 2025-06-26 | 8-K | View |
| 2025-06-16 | 4 | View |
Latest News on CRNX